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In this short review, I am discussing the relatively recent awareness of the role of
symbionts in plant, marine-invertebrates and fungal areas. It is now quite obvious that in
marine-invertebrates, a majority of compounds found are from either as yet unculturable
or poorly culturable microbes, and techniques involving “state of the art” genomic
analyses and subsequent computerized analyses are required to investigate these
interactions. In the plant kingdom evidence is amassing that endophytes (mainly fungal
in nature) are heavily involved in secondary metabolite production and that mimicking
the microbial interactions of fermentable microbes leads to involvement of previously
unrecognized gene clusters (cryptic clusters is one name used), that when activated,
produce previously unknown bioactive molecules.
Keywords: natural product sources, uncultured microbes, poor producing microbes, endophytes, microbe–
microbe interactions
INTRODUCTION
Over the past twenty-plus years, data related to microbes from all sources being involved in the
production of bioactive agents, has grown from being a “suggestion or slight possibility” to now
being recognized, at least in the marine area, as probably being the source(s) of the majority of
bioactive agents that have been reported from marine invertebrates. However, in the vast majority
of cases, the microbe(s) cannot be cultivated under the usual conditions that had been used for
many years. The advances in genomic analysis techniques, particularly in the last five or so years,
has however, permitted the amplification and then the subsequent analysis from a biosynthetic
perspective, of the genes within a single “as yet uncultured” microbe, and thus the identification of
the “source” of the bioactive materials reported from the “host.”
In the case of plant-derived bioactive compounds, what has now occurred with regularity,
are reports of mainly endophytic microbes, usually fungi, but frequently actinobacteria, that will
produce low levels of the “plant metabolite” on fermentation but on subsequent sub-culturing,
the microbe apparently loses its ability to produce the “plant-metabolite.” However, in the last
few years, investigators have begun to “relearn” techniques that used to be very common in the
pharmaceutical industry, but to the ultimate chagrin of academic researchers, were never published
in regular journals, that supplementation of fermentation broths with extracts of parts of the
“nominal producing source,” could “induce or maintain” production of the metabolite of interest.
The other component of “production” that has now come to the fore, is the belated recognition
that in any microbial system, there is constant chemical messaging between microbes in the
microbiome of the host. Whereas microbiologists and co-workers want a single microbe to produce
a given compound, Mother Nature prefers a consortium and thus the recognition that mixed
cultures might well aid in “production” has now become quite apparent, usually via the “switching
on or off” of biosynthetic gene clusters (BGCs) in one or more of the consortium.
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This short review will cover various aspects of the above, not
in depth but relevant up to date references will be provided so





In 1982, the Faulkner group at the Scripps Institute of
Oceanography reported the isolation of renieramycin A
(Figure 1; 1) from the Eastern pacific sponge of the genus
Reniera sp. (Frincke and Faulkner, 1982). This material had
antibiotic properties and its structure was very similar to the
known antitumor agents of the saframycin class that had
been reported 5 years earlier by Takahashi and Kubo (1977),
from the terrestrial microbe, S. lavendulae. Two later papers
(Arai et al., 1979, 1980) gave the structures of saframycins B
(Figure 1; 2) and C (Figure 1; 3), and then of saframycin A,
(Figure 1; 4), respectively. These reports were then followed
in 1988 by the isolation of saframycin Mx 1 (Figure 1; 5)
from the myxobacterium Myxococcus xanthus strain Mx48
(Irschik et al., 1988). Thus in just over 10 years, closely related
antibacterial and antitumor compounds had been isolated from
a streptomycete, a myxobacterium (both terrestrial) and from a
marine sponge. However, these were only the tip of the iceberg,
as the base molecule, naphthyridinomycin, (Figure 1; 6) was
initially reported from Canada in 1974 (Sygusch et al., 1974) and
1975 (Kluepfel et al., 1975), being isolated from the terrestrial
streptomycete Streptomyces lusitanus AY B-1026.
Why is this early work so important from a marine
perspective? In the middle 1980s to early 1990s, the Rinehart
group at the University of Illinois at Urbana, the second group
after the Scheuer group in Hawaii to systematically study marine-
derived compounds, and then later, in conjunction with the
Wright group at Harbor Branch Oceanographic Institution in
Florida, published two back to back papers in the Journal
of Organic Chemistry showing the structures of the cytotoxic
agent ET743 (Figure 1; 7) and its congeners, isolated from the
Caribbean tunicate, Ecteinascidia turbinata (Rinehart et al., 1990;
Wright et al., 1990). These reports were an extension of the
work reported by Holt (1986) in his Ph.D. thesis completed
while in the Rinehart group. That this organism “produced” a
cytotoxic compound or compounds had been reported in 1969
by Sigel et al. (1970). These compounds were obviously built on
the same basic structure as reported for naphthyridinomycin,
the saframycins, and renieramycin. Thus one now had multiple
bioactive compounds that must have been produced by a similar
set of biosynthetic clusters, though it was unknown at the time
what the organism or organisms might be, but microbes were
prime candidates.
ET743 became an approved antitumor drug under the aegis
of the Spanish company PharmaMar and the methods used in its
production included: massive large-scale collections; aquaculture
of the tunicate in sea and in lakes; then partial synthesis using
a marine bacterial product, cyanosafracin B (Figure 1; 8) to
produce cGMP ET743. The story leading to the production
of ET743 has been presented by a number of people, but the
best publications are those from the PharmaMar team (Cuevas
et al., 2000, 2012; Menchaca et al., 2003; Cuevas and Francesch,
2009).
In addition to the publications from the PharmaMar group on
the semisynthetic processes, two other highly relevant reviews are
the one in 2002 by Scott and Williams covering the chemistry
and biology of the tetrahydroquinoline antibiotics (Scott and
Williams, 2002), which was followed in 2015 by a very thorough
review on the ecteinascidins themselves in 2015, again from the
Williams group (Le et al., 2015).
From a microbial aspect there were suggestions that an as yet
uncultured bacterium, Candidatus Endoecteinacidia frumentenis
(AY054370), was involved in the production of these molecules.
This organism was found in ET743-producing E. turbinata
collected in both the Caribbean and the Mediterranean seas
(Moss et al., 2003; Perez-Matos et al., 2007). By use of the
suggestions made by Piel (2006) as to how to utilize symbionts
from invertebrates, and then using the knowledge of the
organization of the BGCs of the saframycins (Li et al., 2008)
and safracin B (Figure 1; 9) (Velasco et al., 2005) as markers,
the Sherman group at the University of Michigan, were able
to identify the “contig” that encoded the NRPS biosynthetic
enzymes involved in the ET743 complex, as well as the probable
producing bacterium, the as yet uncultured microbe Candidatus
Endoecteinascidia frumentensis present in both the Caribbean
and Mediterranean E. turbinata organisms (Rath et al., 2011).
Four years later, the same group directly confirmed the initial
report (Schofield et al., 2015). In the process, they demonstrated
that the producing bacterium, E. frumentensis, may well represent
a member of a new family of Gammaproteobacteria and has
an extensively streamlined genome as found in other symbiotic
microbes (McCutcheon and Moran, 2012), with most of the
genetic machinery being devoted to this complex of compounds
(Kehr and Dittmann, 2015).
MARINE METABOLITES BASED UPON A
TERRESTRIAL BEETLE TOXIN
Mycalamides, Onnamides, and Similar
Molecules
The structure of the toxin pederin (Figure 2; 10) “used” by rove
beetles of the genus Paederus as a protective agent, was first
identified chemically by Italian scientists studying this genus in a
publication in 1952 (Pavan and Bo, 1952). The dermatitis caused
by the toxin has been well described in the literature, with a recent
publication by Cressey et al. (2013) demonstrating the problem
with this toxin.
Following on from the original 1952 publication, in 1965
Carani et al. (Cardani et al., 1965) published an initial structure
which was then revised 3 years later by Matsumoto et al. (1968)
giving the structure shown (Figure 2; 10). This is where the story
might have languished with the compound simply becoming
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FIGURE 1 | Compounds 1 to 9.
an interesting molecule to synthesize by demonstrating novel
chemical methods. Such syntheses have been reported in some
relatively recent publications in the synthetic chemistry literature
(Jewett and Rawal, 2007; Wu et al., 2011). However, in the
late 1980s, the Blunt and Munro group at the University of
Canterbury in New Zealand, published their finding that an
extract of a relatively deep water sponge of the genus Mycale,
collected in cold water, produced bioactive molecules that had
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FIGURE 2 | Compounds 10 to 21.
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antiviral and cytotoxic biological activities, and encompassed the
pederin nucleus within the overall structure. The molecules were
also powerful vesicants, as is pederin. The two molecules were
named mycalamide A (Figure 2; 11) and B (Figure 2; 12) differing
only by a methyl group, but with a 10-fold difference in biological
activity (Perry et al., 1988, 1990).
What is the relationship of such findings to pederin and
Paederus beetles? The following reports in the insect physiology
literature will help uncover the reasons why this was a very
important finding, that led, many years later, to the identification
of the actual “source” of the pederin-related molecules found in
the Mycale sp., and in other sponges, in particular, the Theonella
swinhoei “Yellow variant.” In 1999, a German entomologist,
Rupert Kellner, published a very interesting paper that asked;
“what was the basis of pederin polymorphism in the rove
beetle Paederus riparius?” His suggestion, with data, was that
an endosymbiont was the actual producer of the toxin (Kellner,
1999). Then 2 years later, he reported that pederin biosynthesis
was suppressed in the closely related species, Paederus sabaeus,
if antibiotics were used to remove endosymbionts (Kellner,
2001). Thus there was significant evidence implying a bacterial
component in the production of pederin, and since this occurred
in two different species of the beetle, it might be common to all.
However, to bring the story to its climax, one now has to
return to the marine environment. From 1988 to early 2000,
there were reports that a significant number of sponge extracts
contained pederin-related molecules such as the onnamides, with
onnamide F (Figure 2; 13) being a good example (Vuong et al.,
2001), together with the theopederins, with compounds such
as theopederins K (Figure 2; 14) and L (Figure 2; 15) being
examples of the structural similarities (Paul et al., 2002). Kellner
(2002b) reported that he had identified the endosymbiont as
a very close relative to Pseudomonas aeruginosa and showed
that interspecific transmission of the endosymbionts was related
to the different genetic makeup of individual isolates (Kellner,
2002a).
So how did this work then relate to the “marine-derived
pederin-like compounds”? In a series of papers in the time frame
from 2002 to 2005, Piel demonstrated that he could find the
biosynthetic clusters for pederin in the putative pseudomonad
identified and isolated by Kellner (Piel, 2002), and that these
had an unprecedented diversity of catalytic domains in the first
four clusters in the process (Piel et al., 2004c). Since Piel had
the relevant genetic probes, he collaborated with the Japanese
group led by Fusetani and Matsunaga at the University of Tokyo,
to investigate the production of the closely related onnamides,
isolated from the Japanese sponge Theonella swinhoei (yellow
variant) in warm, shallow waters off of Okinawa, in contrast to the
mycalamide-producer. The pseudomonal probes “lit up” parts of
the sponge metagenome, and they were able to locate the nexus
of the biosynthesis to an as yet uncultivated symbiont (Piel et al.,
2004b). Concomitantly Piel also demonstrated evidence for what
is now known as a “symbiosis island” that permitted horizontal
acquisition of the pederin biosynthetic capabilities in Paederus
fuscipes (Piel et al., 2004a). The details as of that time were
published in a short review in the Journal of Natural Products
in 2005 (Piel et al., 2005), and then in 2011, Kador et al. (2011)
published separate oligonucleotide probes that could be used to
detect pederin producers in Paederus beetles.
Following on from these seminal studies, Wilson and Piel
(2013) demonstrated potential approaches to the study of
uncultivated, or not yet cultivatable microbes, as resources for
novel biosynthetic enzymology. This paper demonstrated the
potential for performing genomic work on very small numbers
of uncultivated bacteria isolated from invertebrate hosts, in
this case, sponges, and tunicates. This was exactly the type of
investigation that Bewley and Faulkner (1998) wished to perform
in the late 1990s when they identified the production of the
cyclic peptides swinholide A (Figure 2; 16) and theopalauamide
(Figure 2; 17) by Theonella swinhoei, and their suggestion,
using the techniques then available (microscopy in general),
that a microbial consortium might be responsible for their
“production.”
In 2014, 1 year after their earlier paper, the Piel group
demonstrated in a seminal publication in Nature, that the
producing organism in T. swinhoei was an as yet uncultured
microbe, and that there were two subtly distinct variations
isolated, TSY-1 and TSY-2 via single cell separation of the sponge
and contents. Both contained a plasmid that contained the
onnamide and polytheonamide BGCs, but further investigation
showed that they differed significantly when BGC clusters that
were chromosomally encoded were studied. Thus the TSY-1
variant in addition to the plasmid-encoded BGCs, also contained
the genes for a further 28 BGCs including cyclotheonamides,
proteusins, and ceramides, plus others. The other strain, TSY-
2 only had seven other BGCs with very little overlap with
TSY-1 metabolites. As a result of these and other studies on
different sponge taxa, the suggestion was made that these were
representative of a new phylum “Tectomicrobia.” Thus these two
microbes contained the necessary genetic machinery to produce
31 of the then 32 known cytotoxins to have been isolated from
this particular sponge at that time (Wilson et al., 2014).
Recently, the Piel group have published the enzymology
involved in the formation of the long peptides such as the
polytheonamides which have repeating D and L amino-acids,
but are ribosomally produced peptides (Morinaka et al., 2014),
with a recent publication by Hayata et al. (2016) demonstrating
syntheses around this structure to produce new ion-channel
cytotoxins. Morionka et al. (2014), was then followed in 2016
by a review demonstrating the metabolic potential of the as yet
uncultivated “Entotheonella” where more information is given
as to the multiplicity of structures that result from this microbe
(Freeman et al., 2016).
Looking at an area where many marine-derived bioactive
compounds have been reported, but none have yet made into
clinical trials, Ueoka et al. (2015) published an extensive paper
on the source of misokinolide A, a compound that differs from
the well-known swinholide A by removal of one double bond in
the ring structure (Figure 2; 18), demonstrating that it too, came
from a non-cultivated Entotheonella but not from T. swinhoei but
from a Discodermia species. Interestingly the protein phosphatase
inhibitor calyculin A (Figure 2;19) produced by Discodermia
calyx, was shown by Wakimoto et al. (2014) to be a product of the
same microbial genus, then in a more thorough paper published
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in 2016, they demonstrated that it is actually produced as a pro-
drug (Wakimoto et al., 2016). Such a pro-drug approach may well
be a protection method to avoid killing the host invertebrate or
even the producing microbe.
To conclude the microbial chemistry aspect of this section,
but now moving back to the terrestrial sphere, there was a
very intriguing report showing the presence of a pederin-like
compound, nosperin (Figure 2; 20) found in a lichen, where
the bacterium was a cyanobacterium, a Nostoc sp., so these
biosynthetic genes are extremely widespread (Kampa et al., 2013).
As mentioned earlier, the structures of pederin and its
derivatives certainly excited synthetic organic chemists and over
the years, effectively all of the molecules that contain the pederin
backbone have been synthesized, even when ring-opened as
in irciniastatin A (Figure 2; 21). This compound was initially
reported by the Pettit group in 2004 (Pettit et al., 2004) and
subsequently reported as psymberin by the Crews group the
same year (Cichewicz et al., 2004) from a different sponge genus.
Careful inspection of the supporting information in the Crews
paper showed that they knew of the same compound under a
different name/genus from the Pettit group, published before
their submission. Thus the Pettit group has priority in the
discovery of this compound structure. Representative examples
of these compounds have been synthesized by considerable
numbers of organic chemists in the last 10 plus years. The
following papers should be consulted by readers interested in the
synthetic processes used (Jewett and Rawal, 2007; Jiang et al.,
2007; Nishii et al., 2009; Wan et al., 2011; Wu et al., 2011,
2012; Mosey and Floreancig, 2012; Floreancig, 2014; Uesugi et al.,
2015). Of these, the review by Mosey and Floreancig (2012)
gives a relatively thorough overview of the isolation, biological
activities, and medicinal chemistry of these agents.
Thus what began as a discussion of the toxin produced by
the blister beetle that was known in Brazilian forests/jungle
and in other parts of the World, led to the ability to identify
and express genetic loci related to the biosynthesis of the
agent, but then “migrated” into areas not even thought to be
possible; that the beetle toxin was in fact, used by biodiversity
(aka Mother Nature) to generate molecules in organisms as
diverse as shallow and deep water marine sponges, in warm
(close to 35◦C) and cold (2◦C) water environments and even
in terrestrial lichens. None of these were even thought of in
the wildest dreams of the original scientists working on beetle
toxins.
Combinatorial Chemistry in Ascidians
In the encrusting ascidians such as Lissoclinum species,
investigators over the years have found a series of bioactive agents
mainly based on cyclic peptides. For many years, the actual source
of the agents, in particular the patellamides, was not known. In
a presentation at a Society of Industrial Microbiology Meeting
very late in 2004, Long et al. (2005) presented evidence that
the probable producer was an as yet uncultivated cyanophyte, a
“Prochloron” species. Unfortunately, this paper was not included
in the printed list of papers presented (only discovered after
the presentation at the meeting), thus in the absence of a dated
presentation, the absolute priority to this group could not be
formally assigned. Long et al. (2005) demonstrating that the
complete Prochloron sp. genome could be moved into an E. coli
host using shotgun cloning techniques. Prochloron samples were
extracted from the cloacal cavities of ten specimens of L. patella,
each showing a matching patellamide composition according to
HPLC analysis of the holobiont extracts. Using bacterial artificial
chromosome techniques and then attempting to express the
patellamide producing genes using primers failed. However, by
use of standard fermentation techniques, clones were obtained
that produced patellamide D Figure 3; 22) and ascidiacylamide
(Figure 3; 23).
FIGURE 3 | Compounds 22 to 25.
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Whilst this paper was in press, the Schmidt group published
similar results using a different L. patella source from that used
by Long et al. (2005; Schmidt et al., 2005). The Schmidt group
used material from the Republic of Palau instead of the Great
Barrier Reef (Long et al., 2005) and identified the relevant gene
clusters in the isolated Prochloron species. Since they had been
working on a full genomic analysis of this symbiont, they had
information available pointing to potential gene biosynthetic
clusters, enabling a rapid assessment of the potential biosynthetic
clusters by expressing them in E. coli. Thus two independent
groups came up with the same source of the patellamides.
The Schmidt group then proceeded over the next few years
to further analyses of the producing symbiont, uncovering
a fascinating series of complex interactions that permitted
substitution of individual aminoacids in these ribosomally
produced products, that had geographic relationships defined in
terms of what mixture of patellamides and the closely related
trunkamides were produced by individual ascidians. For the
interested reader, a significant number of publications related to
this symbiotic relationship have been published by the Schmidt
group and their collaborators. These should be perused in
detail to demonstrate the complexity of the interactions involved
(Donia et al., 2011; Kwan et al., 2012, 2014; Schmidt et al., 2012;
Tianero et al., 2012, 2015; Adnani et al., 2014; Schmidt, 2014,
2015). The most current paper is one published very recently
in Applied and Environmental Microbiology demonstrating the
intimate involvement of the microbe in this process (Lin et al.,
2016).
Source of Bryostatins in Bugula neritina
The bryozoan B. neritina first came to the attention of natural
product chemists when Pettit reported the isolation of bryostatin
3 (Figure 3; 24), and then over the next few years, elucidated
the structures of 18 bryostatins, all isolated from massive wild
collections of B. neritina either in the Gulf of Florida, or other
coastal areas of the US, with a massive collection in Palos
Verdes, California that led to the isolation of gram quantities of
bryostatin 1 by workers at NCI-Frederick (Schaufelberger et al.,
1991). The story up through late 2011 was given by in a review
by Newman published as a chapter in the second edition of
“Anticancer Agents from Natural Products” in 2012 (Newman,
2012). Over 80 clinical trials of bryostatin 1 (Figure 3; 25)
with or without other cytotoxic agents have been reported over
the years at Phase I or Phase II levels against various cancers,
but none have demonstrated activities that have warranted
continuation. Currently there is one trial shown at the Phase II
level in Alzheimer’s disease (NCT02431468) under the aegis of
Neurotrope Inc.
The actual producing agent in B. neritina was unknown until
the report by Haygood and Davidson (1997), demonstrating
that the larvae of bryostatin-producing bryozoans contained a
previously unknown bacterium that could not be cultured, but
was observable in the pallial sinus of the larvae. This microbe was
named as “Candidatus Endobugula sertula” by Haygood, and over
the next few years, this microbe was found in other examples of
B. neritina but appeared to have a latitudinal restriction and strain
variation with depth. These phenomena were well investigated by
both the Haygood group on the Pacific Coast, and by the Lopanik
group in the Atlantic Coast of the USA. The relevant publications
are (Davidson and Haygood, 1999; Davidson et al., 2001; Lopanik
et al., 2004, 2006; Sharp et al., 2007; Linneman et al., 2014).
The role of bryostatin within the larvae appears to be a
protective measure. This was shown by investigation of the effect
of removing the symbiont via antibiotic treatment, followed
by predation studies on larvae containing the symbiont, versus
those without it. The levels of bryostatins were also measured in
these experiments and they demonstrated that without bryostatin
production, the larvae were “food” for predators (Lopanik et al.,
2004). What was of immense import, however, was the work
performed by the Sherman group at the University of Michigan,
in conjunction with the Haygood and Lopanik groups, where they
identified the putative bryostatin gene cluster from “Candidatus
Endobugula sertula” in 2007 (Sudek et al., 2007). This initial
paper was followed up by the Sherman group in 2008 (Lopanik
et al., 2008) and 2010 (Buchholz et al., 2010), leading to a very
recent paper demonstrating the “holobiont fitness” via specific
interactions with host organism PKC enzymes from the Lopanik
group (Mathew et al., 2016). Thus even if the organism’s symbiont
cannot yet be cultivated, its effect and product can be measured
by modern techniques.
Finally, a very interesting paper was published recently
demonstrating that molecules based on the bryostatin skeleton
can have significant effects on viral replication. Paul Wender at
Stanford University, who for many years has been involved in
modifying the basic structure of the bryostatins and other potent
marine-derived biologically active natural products, producing
bioactive truncated structures. In the case of the bryostatin-
based compounds they are known colloquially as “bryologs,”
and Wender et al. published a paper in 2016 demonstrating
the inhibition of Chikungunya virus-induced cell death, by a
relatively simple bryostatin analog, that does not appear to use
a PKC pathway, in contrast to the usual mechanism of action of
bryostatins (Staveness et al., 2016). Thus close to 50 years since
the first reports of bryostatins, they are still an active structural
class for synthetic chemists to modify.
PLANT-SOURCED COMPOUNDS AND
MICROBES
In a significant number of cases nowadays, there have been
reports in the literature that have questioned the “actual
source” of biologically active materials that are approved
pharmaceuticals, or were leads to the approved drug entity. These
are often, though not exclusively, antitumor agents in clinical use
that were isolated from plants. Very few came from plants quoted
to have some medicinal properties, with the majority found from
bioactivity-directed isolation techniques under the funding and
collection programs of the US National Cancer Institute. In
contrast to the microbes referred to above, these “endophytes” are
usually able to initially be fermented and do produce the “plant
metabolite” albeit in very low yield. In general, on subsequent
refermentation, the yields decreased and frequently after one or
more sub-culturings, the compound was no longer observable.
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Thus initial reports were criticized for not accounting for “carry-
over” of the active agent during the microbe’s isolation. This
latter comment, and the inability to successfully repeat many
fermentations with continued production of the metabolite, was
seen over the years for “plant-derived” compounds such as taxol,
camptothecin, the vinca alkaloids and others.
However, if researchers in this field had delved into the
literature, or had corresponded with any scientist who had
experience in the optimization of production of microbial
metabolites in “pre-genomic times,” almost all of whom would
have been from the antibiotic industry where publications were
via patents, not scientific journals, then they would have found
that in 1998, Strobel reported increasing the yield of taxol and
maintaining it by using specific plant “extracts” to supplement
the media (Li et al., 1998). Coming into the present, in a very
nice example, the Oberlies group demonstrated that extracts from
the leaves of the plant that “produced” the flavolignins silybin A
and B (Figure 4; 26, 27), reversed the loss shown on subculturing
by growing on a medium supplemented with autoclaved leaves
of the nominal producing plant, Silybum marianum (El-Elimat
et al., 2014). The previous year, the Proksch group in Germany
published an excellent review on endophytes and their products,
also pointing out the same phenomenon (Aly et al., 2013). This
type of supplementation was used not only in plant symbiont
studies as very recently, the Ilan group in Israel demonstrated that
addition of sponge skeletons to a microbial culture increased the
“richness” of arsenic-tolerant bacteria from Theonella swinhoei
(Keren et al., 2016).
That endophytes are one of the producers (in some cases)
is shown by the large amount of work performed over the
years on the “actual source” of the well-studied “plant product,”
maytansine (Figure 4; 28). From early days, its resemblance
to a well-known series of bacterial metabolites led people to
speculate on the actual source of the material, with one valid
idea being conversion from the bacterial metabolite, ansamitocin
P3, which differs only in an ester (Figure 4; 29) known to be
produced in the rhizosphere of Maytenus species. This molecule
would subsequently be taken up from the plant’s rhizosphere
and modified to produce maytansine by transesterification. In
recent excellent work by the Spiteller group, in a paper in 2014,
working with a Putterlickia species (one of the first plants from
which maytansine was isolated), demonstrated that microbes in
the plant’s rhizosphere were the source of maytansine, without
any plant involvement (Kusari et al., 2014).
In contrast, and quite unexpected, were the findings reported
from the same group in their recent 2016 paper. Using a
maytansine-producing Maytenus serrata plant from Cameroon,
and following the biosynthesis of maytansine in this plant,
they showed a very strong relationship between endogenous “as
yet uncultivated microbes” and the production of the desired
metabolite, but demonstrated that the required chlorination
step definitively occurred in the rhizosphere microbes. However,
an unexpected finding was that the starter unit, 3-amino-5-
hydroxybenzoic acid (AHBA), was produced by both these
microbes and the plant. So depending upon the geographic area
and perhaps the genus and species of the “nominal producing
plant,” the route to the same compound can differ (Kusari et al.,
2016). From their earlier data, this was not the expected result,
but the evidence is there.
These findings also imply the usage of quorum sensing in
the interactions between not only the endophyte/rhizosphere,
but also with the plant itself (Kusari et al., 2015). Thus findings
such as these need to be considered in any evaluation of plant
biotechnology as a route to metabolite production, as plant
explants are not axenic.
That quorum sensing agents of various chemical classes, not
only the simple compounds usually mentioned in the microbial
literature, are used in these interactions was shown by other
recent papers from the Spiteller group (Wang et al., 2015; Li et al.,
2016a). The short review published by Ludwig-Muller (2015)
appears to be quite prescient in light of these recent papers,
and should be read in conjunction with the Spiteller group
publications, not forgetting the earlier work by Strobel that really
began this area of investigation as far as plants are concerned.
FUNGAL–BACTERIAL INTERACTIONS
Though interactions on an organism to organism scale between
fungi and bacteria are well known, there is one particular
interaction that is most unusual, and that is where the toxins,
normally considered to be fungal products, are in fact from a
symbiotic bacterium in one structure and from a subsequent
chemical modification by the host fungus in the other. In 2005
to 2006, the Hertweck group demonstrated that the “fungal
toxin” rhizoxin (Figure 4; 30) was not produced by a Rhizopus
fungal species, but from a symbiotic bacterium later identified
as a Burkholderia species, and then demonstrated the variety of
structures that could be obtained from culturing the bacterium
outside of the fungus (Partida-Martinez and Hertweck, 2005,
2007; Scherlach et al., 2006; Partida-Martinez et al., 2007).
However, the story did not end there, as later work from
the same group demonstrated that a much more involved
process occurred. The bacterium actually produced a mono-
epoxy derivative, WF-1360F (Figure 4; 31) originally thought to
be an artifact, that was biologically active as an antitubulin agent,
and then they found other Rhizopus species that only produced
this mono-epoxy compound but contained the endophytic
bacterium. By some very clever investigative work involving
transfer of the bacterium between fungal species, in 2012 it was
proven that the host fungus actually converts the mono-epoxy
WF-1360F to the diepoxy derivative, rhizoxin, since the required
P450 enzyme does not occur in all Rhizopus species (Scherlach
et al., 2012). It should also be pointed out that both of these
compounds are tubulin interactive agents in their own right.
Thus Nature has evolved a ternary production system, and
similar systems may well be operative in this type of interaction
in other organism complexes, though binary systems are more
common. Examples can be found in the comprehensive review
by Scherlach et al. (2013) Annual Reviews of Microbiology,
and in the biosynthesis of other polyketides when a different
Burkholderia species was co-cultured with Rhizopus microspores
(Ross et al., 2014). Also in 2014, the Hertweck group published
an article demonstrating how bacteria could enter fungi via an
Frontiers in Microbiology | www.frontiersin.org 8 November 2016 | Volume 7 | Article 1832
fmicb-07-01832 November 16, 2016 Time: 14:6 # 9
Newman Uncultured Microbes as Compound Sources
FIGURE 4 | Compounds 26 to 38.
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“active” process, thus answering how this symbiotic relationship
could have occurred (Moebius et al., 2014). Obviously this is
only the beginnings of the potential interaction(s) but it does
demonstrate that what appears to be “gospel” often is not.
MIMICKING In situ MICROBIAL
INTERACTIONS
In the environment, irrespective of whether it is marine or
terrestrial in nature, microbes from all kingdoms (Archaea,
Prokarya, and Eukarya) are in close intimate contact with each
other, as mentioned above in the discussion on maytansine, and
chemical messages are exchanged between and within organisms
from all kingdoms. These messages range from simple lactones to
peptides and may be species specific or be capable of interacting
across kingdoms.
It was realized some years ago, following inspection of the
full genomes of fungi and bacteria, that there were many more
potential BGCs than accounted for by the molecules that had
been found from the “simple” fermentations that had been
used for the previous 60 plus years. These “cryptic clusters”
were sometimes found to be under some form of epigenetic
control, so when small molecules that were demethylase or
histone deacetylase (HDAC) inhibitors, were added to a single
microbe fermentation, the “mixture” could produce molecules
that had not previously been reported. A series of excellent papers
demonstrating these techniques were published by the Cichewicz
group at the University of Oklahoma in 2009–2010 and these
should be consulted for this type of experimentation (Fisch et al.,
2009; Henrikson et al., 2009; Cichewicz, 2010; Cichewicz et al.,
2010).
Working with fungi, in 2006 the Keller group reported on the
potential for genomic control in Aspergillus and demonstrated
that contrary to the then “current dogma,” secondary metabolite
biosynthetic clusters in fungi, or at a minimum in Aspergillus, are
not randomly spread across chromosomes but are usually found
as “groupings” on one or two very spatially close chromosomes
(Bok et al., 2006). Very significant work on fungal secondary
metabolite control has been performed by Keller and her
associates over the last 10 years, demonstrating that there are
well over 100 previously unrecognized secondary metabolite
clusters in some species, and that exquisite control mechanisms
are present, with their latest paper demonstrating that plant-like
isoquinolines are present in Aspergillus fumigatus (Baccile et al.,
2016).
In addition to looking for control via the use of epigenetic
modulators, or using endogenous genetic controls, a simple
system that mimics what happens in Nature, though starting with
just two dissimilar microbes, has led to the identification of novel
agents not seen on fermentation of the individual microbes in
separate vessels.
Before giving the results of some of these more modern
experiments, it is necessary to point out for the record, that
back in the late 1960s to early 1970s, microbiologists were
interested in what might occur if “signal systems” could be set
up between individual microbes. These ideas led to a device
known as the “EcoloGen” which was originally produced by New
Brunswick Scientific in the early 1970s. Effectively, this was a
central chamber with four cylindrical vessels coming off at 90◦
to each other, with the openings to the central vessel able to
be blocked, or have specific ionic or molecular weight filters
interposed between each individual side vessel and the central
one. This would permit the cultivation of up to five different
microbes and allow molecules to pass between them if the filter(s)
permitted such transfer. The author used one of these devices
in the pharmaceutical industry at that time, but the analytical
systems were not refined enough, 40 plus years ago, to permit
identification of “induced metabolites,” only that their new, or
improved biological activities, could be measured as producers
of “antibiotic activity.”
The publication by Martin in 1974 may have been the
first to demonstrate the value of this instrument in studying
effects on the cyanophyte Gomphosphaeria aponina when
attempting to evaluate control of toxic blooms in fresh water
(Martin et al., 1974). Then in 1978 there was a report from
Canadian scientists commenting on the use of the EcoloGen
to study the effects of antibiotic treatment on experimental
mixed infections, perhaps a reversal of what is done today
with mixed cultures (Lebrun et al., 1978). Finally, the last
original publication that I can find, was another by Martin and
Martin (1986), studying effects of growth inhibitors on Hydrilla
verticillata, an invasive fresh water plant, though I have little
doubt, due to my own experience, that many experiments in
industry were never published in academic journals. Today,
the modern technique is the use of diffusion chambers on a
micro-scale to induce the fermentation of sponge-associated or
other host bacteria, but though the investigators may not have
been aware of the earlier methods, these effectively duplicated
the earlier concept with newer methodologies (Steinert et al.,
2014).
Perhaps the first formal reports of activity from designed
experiments in co-culture were those in 1994 by Sonnenbichler
et al. (1994) and then in Burgess et al. (1999). However, in both
of these reports, only increased biological activity was reported.
Then in 2001, the Fenical group at the Scripps Institution
of Oceanography in California, reported the production of a
new antibiotic, pestalone (Figure 4; 32) from challenging a
marine fungus, Pestalotia sp., with a marine α-proteobacterium
(Cueto et al., 2001). Further work with the same bacterium
and the marine-derived fungus Libertella sp., yielded the new
cytotoxic diterpenoids, libertellenones A–D (Figure 4; 33–
36), reported in 2005 (Oh et al., 2005). In 2007, the same
group reported the production of the cyclic depsipeptides
the emericellamides A and B (Figure 4; 37, 38) when the
marine-sourced fungus Emericella sp., was co-cultured with
the obligate marine bacterium, Salinispora arenicola (Oh et al.,
2007). Since that time, a number of novel metabolites have
been reported in the literature with some representative
examples being discussed in the preamble to an article by the
Jaspars’ group in 2013, covering their findings on co-culture
of Aspergillus fumigatus with the type strain of Streptomyces
bulli, a bacterium from an hyper-arid soil (Rateb et al.,
2013).
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CONCLUSION
In the last 2–3 years, there have been a significant number
of papers published that give further information on how
one may use the types of interactions discussed above, and
most importantly, describe methodologies that can be used to
“interrogate” the results. These include, but are not limited to:
discussion of eliciting secondary metabolism in actinomycetes
(Seyedsayamdost et al., 2012; Abdelmohsen et al., 2015;
Rutledge and Challis, 2015); methodologies for determining the
compounds expressed (Adnani et al., 2014; Luzzatto-Knaan et al.,
2015; Medema and Fischbach, 2015; Mohimani and Pevzner,
2016); analyses of the biosynthetic clusters identified in fungi
to published natural product structures (Li et al., 2016b); small-
scale plate-based techniques for fungal co-culture (Bertrand et al.,
2014); on-demand production of secondary metabolites (Bode
et al., 2015); mixed culture of endophytes (Chagas et al., 2013);
metabolomics in induced cultures (Derewacz et al., 2015; van
der Lee and Medema, 2016; Zhang et al., 2016a,b; Ziemert et al.,
2016); use of synthetic biological techniques to further expand
the chemical biodiversity discovered (Smanski et al., 2016); and
a recent review of the array of approaches to study such cryptic
cluster expression by Zarins-Tutt et al. (2016).
Finally, there are three excellent papers on materials from
symbioses in plants, marine organisms, and other animals that
should be read by everyone interested in this topic. The first is a
truly excellent compendium of material from plant and marine
invertebrate symbioses (Florez et al., 2015), the second covering
animal–microbe interactions including the major compounds
from insect–microbe symbioses (Kieft and Simmons, 2015),
whilst the third discusses the “utility” of such materials as signal
molecules (Hillman and Goodrich-Blair, 2016).
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